The present invention involves a method of preparing Mirabilitum Praeparatum by pure strain fermentation and its application in treating infectious and inflammatory diseases, as well as health products and cosmetics. The method involves blending the ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai with Mirabilite (Na.sub.2SO.sub.4.10H.sub.2O) according to a certain ratio as culture media and the pure strain Penicillium rubens as zymocyte, and then fermenting under a certain temperature. The Mirabilitum Praeparatum prepared by present method is different from that of prepared by traditional technology significantly, and the present invention possesses more advantages than the traditional method. The Mirabilitum Praeparatum prepared by present method, its extract shows powerful antibacterial and anti-inflammatory activities, which can be prepared into pharmaceutical preparations to treat infectious diseases of mucous membrane and skin, such as cavum oris ulcer, paradentosis, glossitis, rhinitis, laryngopharyngitis, dermatitis, otitis media, uterine cervicitis, kysthitis, and other health products and cosmetics.

Methods and compositions for reducing, (e.g., controlling, inhibiting, preventing, protecting against, or minimizing) staining, (e.g., resulting from stains and/or discoloration) of teeth in the oral cavity are provided. Aspects of the compositions include a component or components (e.g., a wax and an oil) capable of reducing staining of the teeth. In some instances, the compositions further include an agent which enhances the mineralization of teeth.

Particles obtainable by polymerization of a siloxane which has at least one (meth)acrylate group of the formula (I)
—O—C(O)—CR═CH.sub.2  (I)
where R=—H or —CH.sub.3, which are characterized in that the siloxane has an average molar ratio of groups of the formula (I) to Si atoms of less than 0.1 are provided.

A method of preparing a zinc citrate-containing oral care composition, the method comprising: (a) adding zinc oxide to a solution of citric acid in a solvent to form a suspension; (b) agitating the suspension until a clear solution is obtained; and (c) adding an additional oral care ingredient to the solution obtained in (b). Also, a method of preparing a zinc citrate-containing oral care composition, the method comprising: (a) adding citric acid to a suspension of zinc oxide in a solvent; (b) agitating the suspension until a clear solution is obtained; and (c) adding an additional oral care ingredient to the solution obtained in (b). In both methods, steps (a) and (b) are carried out at a temperature of from 10° C. to 50° C. and the molar ratio of zinc oxide to citric acid in step (a) is about 3:2.

The object of the present disclosure is a method for treating keratinous material, in particular human hair, involving applying the following to the keratinous material a first composition (A) comprising, relative to the total weight of the composition (A) (A1) less than 10% by weight of water and (A2) one or more organic C.sub.1-C.sub.6 alkoxy silanes and/or their condensation products, and a second composition (B) comprising (B1) Water, (B2) at least a first surfactant, and (B3) at least a second surfactant which is structurally different from the first surfactant (B2).

A method for producing a solid powder includes the following steps: (1) mixing the powders to obtain a material A, in which the powders include a flaky filler, a spherical filler, and a pigment; and mixing a natural polysaccharide with water, then adding an emollient moisturizer and an emulsifier to obtain a material B; (2) mixing the material A and the material B, and then adding a preservative to obtain a dispersion; (3) filling the dispersion into a mold; (4) freezing the dispersion to a preset low temperature, and then demolding to obtain a semi-finished product; and (5) drying the semi-finished product to obtain a finished product in a lyophilizer.

A compacted perfume composition comprising at least three Performance Markers A1, each of them at a level higher than or equal to their specific Critical Compaction Concentration (CCC), respectively, the total concentration of said Performance Markers being higher than 1% by weight of the compacted perfume composition; at least one Performance Vehicle A2, the total concentration of said Performance Vehicle being higher than 10% by weight of the compacted perfume composition; and at least one Performing Diluent B1, the total concentration of said Performing Diluents being higher than 5% by weight of the compacted perfume composition.

The disclosure describes compositions for dental varnishes, methods of making the compositions, and methods of using the compositions, such as in the treatment and prevention of hypersensitivity in teeth.

It is described a process, starting from fishbones, for the production of a material having properties of physical type solar filter and photoprotective boosting agent, formed by particles of hydroxyapatite or hydroxyapatite substituted with metal ions, optionally mixed with calcium triphosphate and with metal oxides. Are also described the material obtained through the process and cosmetic or plant sunscreen compositions that comprise said material.

The present application provides a process for synthesizing squalane and squalane derivatives as alternatives for squalene extracted from natural products. In particular, this application provides a process for producing a cosmetic, personal care or pharmaceutical composition comprising the steps of: (a) combining a Cn-fatty acid and a Cm-fatty acid with a solvent to form an electrolysis reaction mixture, wherein the sum of n+m is 32; and performing a Kolbe electrolysis on the electrolysis reaction mixture; (b) subjecting the product of step (a) to a hydroisomerization reaction to produce a C30 saturated, branched hydrocarbon or a mixture of C30 saturated, branched hydrocarbons; and (c) formulating the C30 saturated, branched hydrocarbon with one or more ingredients to produce the cosmetic, personal care or pharmaceutical composition. Also provided are cosmetic, personal care pharmaceutical compositions that comprise squalane and/or squalane derivatives produced by this process.